Suppr超能文献

乳腺癌诊断后的体重增加与全因死亡率:系统评价与荟萃分析

Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis.

作者信息

Playdon Mary C, Bracken Michael B, Sanft Tara B, Ligibel Jennifer A, Harrigan Maura, Irwin Melinda L

机构信息

Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT (MCP, MLI, MBB, MH); Yale Cancer Center, New Haven, CT (MLI, TBS); Dana-Farber Cancer Institute, Boston, MA (JAL).

出版信息

J Natl Cancer Inst. 2015 Sep 30;107(12):djv275. doi: 10.1093/jnci/djv275. Print 2015 Dec.

Abstract

BACKGROUND

Overweight and obesity are associated with breast cancer mortality. However, the relationship between postdiagnosis weight gain and mortality is unclear. We conducted a systematic review and meta-analysis of weight gain after breast cancer diagnosis and breast cancer-specific, all-cause mortality and recurrence outcomes.

METHODS

Electronic databases identified articles up through December 2014, including: PubMed (1966-present), EMBASE (1974-present), CINAHL (1982-present), and Web of Science. Language and publication status were unrestricted. Cohort studies and clinical trials measuring weight change after diagnosis and all-cause/breast cancer-specific mortality or recurrence were considered. Participants were women age 18 years or older with stage I-IIIC breast cancer. Fixed effects analysis summarized the association between weight gain (≥5.0% body weight) and all-cause mortality; all tests were two-sided.

RESULTS

Twelve studies (n = 23 832) were included. Weight gain (≥5.0%) compared with maintenance (<±5.0%) was associated with increased all-cause mortality (hazard ratio [HR] = 1.12, 95% confidence interval [CI] = 1.03 to 1.22, P = .01, I(2) = 55.0%). Higher risk of mortality was apparent for weight gain ≥10.0% (HR = 1.23, 95% CI = 1.09 to 1.39, P < .001); 5% to 10.0% weight gain was not associated with all-cause mortality (P = .40). The association was not statistically significant for those with a prediagnosis body mass index (BMI) of less than 25 kg/m(2) (HR = 1.14, 95% CI = 0.99 to 1.31, P = .07) or with a BMI of 25 kg/m(2) or higher (HR = 1.00, 95% CI = 0.86 to 1.16, P = .19). Weight gain of 10.0% or more was not associated with hazard of breast cancer-specific mortality (HR = 1.17, 95% CI = 1.00 to 1.38, P = .05).

CONCLUSIONS

Weight gain after diagnosis of breast cancer is associated with higher all-cause mortality rates compared with maintaining body weight. Adverse effects are greater for weight gains of 10.0% or higher.

摘要

背景

超重和肥胖与乳腺癌死亡率相关。然而,诊断后体重增加与死亡率之间的关系尚不清楚。我们对乳腺癌诊断后的体重增加以及乳腺癌特异性、全因死亡率和复发结局进行了系统评价和荟萃分析。

方法

通过电子数据库检索截至2014年12月的文章,包括:PubMed(1966年至今)、EMBASE(1974年至今)、CINAHL(1982年至今)和Web of Science。语言和发表状态不受限制。纳入测量诊断后体重变化以及全因/乳腺癌特异性死亡率或复发的队列研究和临床试验。参与者为年龄18岁及以上的I-IIIC期乳腺癌女性。固定效应分析总结了体重增加(≥5.0%体重)与全因死亡率之间的关联;所有检验均为双侧检验。

结果

纳入12项研究(n = 23832)。与体重维持(<±5.0%)相比,体重增加(≥5.0%)与全因死亡率增加相关(风险比[HR] = 1.12,95%置信区间[CI] = 1.03至1.22,P = 0.01,I² = 55.0%)。体重增加≥10.0%时,死亡风险更高(HR = 1.23,95% CI = 1.09至1.39,P < 0.001);体重增加5%至10.0%与全因死亡率无关(P = 0.40)。对于诊断前体重指数(BMI)小于25 kg/m²的患者(HR = 1.14,95% CI = 0.99至1.31,P = 0.07)或BMI为25 kg/m²及以上的患者(HR = 1.00,95% CI = 0.86至1.16,P = 0.19),该关联无统计学意义。体重增加10.0%或更多与乳腺癌特异性死亡风险无关(HR = 1.17,95% CI = 1.00至1.38,P = 0.05)。

结论

与维持体重相比,乳腺癌诊断后体重增加与更高的全因死亡率相关。体重增加10.0%或更高时,不良影响更大。

相似文献

8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

10
Breast cancer: pathogenesis and treatments.乳腺癌:发病机制与治疗方法
Signal Transduct Target Ther. 2025 Feb 19;10(1):49. doi: 10.1038/s41392-024-02108-4.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验